Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dna X (SONM) Research & Development (2018 - 2025)

Dna X's Research & Development history spans 8 years, with the latest figure at $181000.0 for Q3 2025.

  • Quarterly results put Research & Development at $181000.0 for Q3 2025, down 74.69% from a year ago — trailing twelve months through Sep 2025 was $15.2 million (up 473.85% YoY), and the annual figure for FY2024 was $14.2 million, up 703.33%.
  • Research & Development for Q3 2025 was $181000.0 at Dna X, down from $909000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $12.5 million in Q4 2024 to a low of -$135000.0 in Q3 2022.
  • The 5-year median for Research & Development is $1.1 million (2022), against an average of $2.5 million.
  • The sharpest move saw Research & Development plummeted 102.46% in 2022, then soared 1250.65% in 2024.
  • Year by year, Research & Development stood at $3.9 million in 2021, then crashed by 68.5% to $1.2 million in 2022, then decreased by 24.04% to $926000.0 in 2023, then soared by 1250.65% to $12.5 million in 2024, then crashed by 98.55% to $181000.0 in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $181000.0, $909000.0, and $1.6 million for Q3 2025, Q2 2025, and Q1 2025 respectively.